From Wikipedia, the free encyclopedia
- This is a Korean name; the family name is Shin.
Incheol Shin (born 1957-12-23) is a South Korean cancer researcher and, since 2005, a faculty member at the Department of Life Science, College of Natural Science, Hanyang University, Seoul, Republic of Korea. He was formerly a post-doc and then research faculty at Vanderbilt Ingram Cancer Center in Nashville, Tennessee, U.S.A.[1]
[edit] Publications
- I Shin; FM Yakes, F Rojo, NY Shin, AV Bakin, J Baselga and CL Arteaga (16 September 2002). "PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization". Nature Medicine. doi:10.1038/nm759.
- Bong Gu Kang; June Ho Shin, Jae Kyu Yi, Ho Chul Kang, Jong Joo Lee, Hyen Seok Heo, Ji Hyung Chae, Incheol Shin, Chul Geun Kim (May 2007). "Molecular and Cellular Biology" 27 (10): p. 3578-3588. American Society for Microbiology. doi:10.1128/MCB.01808-06.
- Incheol Shin; Jeniffer Ed, Swati Biswas, P. Charles Lin, Raymond Mernaugh and Carlos L. Arteaga (April 1, 2005). "Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies" 65: p. 2815-2824. Cancer Research.
[edit] References